Elasmogen Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Elasmogen Ltd's estimated annual revenue is currently $2.8M per year.
- Elasmogen Ltd's estimated revenue per employee is $155,000
Employee Data
- Elasmogen Ltd has 18 Employees.
- Elasmogen Ltd grew their employee count by 0% last year.
Elasmogen Ltd's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and founder | Reveal Email/Phone |
2 | Senior Scientist | Reveal Email/Phone |
3 | Senior Scientist | Reveal Email/Phone |
4 | Oncology Team Leader, Principal Research Scientist | Reveal Email/Phone |
5 | Research Scientist | Reveal Email/Phone |
6 | Senior Scientist Program Lead | Reveal Email/Phone |
7 | Research And Development Scientist | Reveal Email/Phone |
Elasmogen Ltd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Elasmogen Ltd?
Elasmogen Ltd is a next generation therapeutic biologics company discovering and developing soloMERsâ„¢ for the treatment of auto-immune mediated, inflammatory diseases. Utilising its unique soloMERâ„¢ platform, Elasmogen exploits the power of biologics as drugs but in small, simple, and stable formats that are amenable to site-specific delivery.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 18 | -40% | N/A |
#2 | $2.4M | 18 | -33% | N/A |
#3 | $1.4M | 18 | -18% | N/A |
#4 | $1.4M | 18 | -10% | $406.5M |
#5 | $1.4M | 18 | -33% | $173M |